In this cohort, TB-IRIS patients had significantly lower blood CD4 T-cell counts compared to non-IRIS patients at baseline, as previously described [8, 42], and we observed a significant expansion in the frequency of Mtb-specific IFNγ+CD4+ T cells 2 weeks after the initiation of ART. The gene discussed is IFNG; the disease is tuberculosis.